Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Leukemia, Myeloid, Chronic-Phase 3Leukemia, Myeloid, Acute 2Leukemia 2Relapsed Pediatric Solid Tumor 1Recurrence 1Prostatic Neoplasms 1Neoplasms 1Mastocytosis, Systemic 1Lymphoma, T-Cell, Peripheral 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, B-Cell 1Gastrointestinal Stromal Tumors 1Diffuse Intrinsic Pontine Glioma 1Carcinoma, Non-Small-Cell Lung 1

Interventions

midostaurin 1masitinib 1Phlebotomy 1Dasatinib 1Cladribine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Mastocytosis, Systemic × Dasatinib × Clear all
NCT00979160 2009-09-18

Evaluation of Response of Dasatinib to Treat Mastocytosis

Federico II University

Phase 2 Unknown
30 enrolled
Myeloid

Mastocytosis, Systemic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡